Last checked at 27 Nov 2020 12:12
LONDON MARKET MIDDAY: Indivior Drops On Reckiitt's GBP1 Billion Claim
LONDON MARKET MIDDAY: Indivior Drops On Reckiitt's GBP1 Billion Claim
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades44,949
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,026.00
Bid:
12,008.00
Ask:
12,012.00
Change:
674.00 (5.94%)
Spread:
4.00 (0.033%)
Open:
11,890.00
High:
12,096.00
Low:
11,790.00
Prev. Close:
12,026.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.27 Nov 2020 11:55
LIVE MARKETS-How is lending holding up?
* European shares flat* London stocks underperform, down 0.5%* BBVA and Sabadell end tie-up talks, Sabadell shares down 13%Nov 27 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoug...
Read more27 Nov 2020 10:11
GLOBAL MARKETS-Stocks rack up the records, dollar sings the blues
* Highly anticipated vaccine facing more scrutiny* Equity markets ready for record highs* U.S. markets on shortened hours after Thanksgiving holiday* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn* Graphic: World FX rates in 2020 http://tms...
Read more27 Nov 2020 09:58
WRAPUP 2-Britain presses on with AstraZeneca vaccine amid questions over trial data
* Britain asks regulator to assess shot for rollout* Philippines says it will secure millions of doses* Experts raise doubts over robustness of trial results* AstraZeneca CEO says likely to run an extra global trial* EXPLAINER-Vaccine trial efficacy ...
Read more27 Nov 2020 09:58
WRAPUP 3-Britain and other nations press on with AstraZeneca vaccine amid trial questions
* Britain asks regulator to assess shot for rollout* Thailand signs deal for 26 million doses of vaccine* Philippines says it will secure 2.6 million doses* Experts raise doubts over robustness of trial results* AstraZeneca CEO says likely to run an ...
Read more27 Nov 2020 09:58
WRAPUP 1-Britain presses on with AstraZeneca vaccine amid questions over trial data
* Britain asks regulator to assess shot for rollout* Philippines says it will secure millions of doses* Experts raise doubts over robustness of trial results* Astra CEO says likely to run an extra global trialBy Alistair Smout and Karen LemaLONDON/MA...
Read more27 Nov 2020 09:03
FOREX-Dollar edges down, set for weekly loss; Aussie and Kiwi rise
* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5ELONDON, Sept 7 (Reuters) - The dollar fell in early London trading on Friday and was on track for a weekly loss against a basket of currencies, even as the equity market rally ran out of s...
Read more27 Nov 2020 08:22
UPDATE 1-Vaccine developer SK Bioscience targets IPO in first half of 2021
(Adds detail)SEOUL, Nov 27 (Reuters) - South Korean drug company SK Bioscience aims to seek a domestic stock market listing in the first half of next year, it said on Friday.The plan follows successful initial public offerings (IPOs) by its affili...
Read more27 Nov 2020 07:41
LIVE MARKETS-On the radar: banking setback, Unilever end of an era
Nov 27 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comON THE RADAR: BANKING SETBACK, UNILEVER END OF AN ERA (0740 GMT)While inv...
Read more27 Nov 2020 07:16
No reason to worry about Oxford/Astra vaccine, UK minister says
LONDON, Nov 27 (Reuters) - British housing minister Robert Jenrick said there was no reason for anyone to be concerned about the data behind the Oxford and AstraZeneca vaccine and said the independent regulator would work to assess it."I don't thi...
Read more27 Nov 2020 06:13
UPDATE 5-Oil prices set for weekly gain ahead of OPEC+ meeting
(Updates prices)By Ahmad GhaddarLONDON, Nov 27 (Reuters) - Oil prices were mixed on Friday but remained on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.Brent crude for January rose 19 cents, or 0.4%, to $47....
Read more27 Nov 2020 06:13
UPDATE 3-Oil prices set for weekly gain ahead of OPEC+ meeting
(Updates throughout, adds comment, changes dateline)By Ahmad GhaddarLONDON, Nov 27 (Reuters) - Oil prices were mixed on Friday but remained on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.Brent crude for Janu...
Read more27 Nov 2020 06:13
UPDATE 4-Oil prices set for weekly gain ahead of OPEC+ meeting
(Updates prices)By Ahmad GhaddarLONDON, Nov 27 (Reuters) - Oil prices were mixed on Friday but remained on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.Brent crude for January rose 35 cents, or 0.7%, to $48....
Read more27 Nov 2020 06:13
UPDATE 2-Oil drops as supply concerns, vaccine doubts sap rally
(Updates prices)By Aaron SheldrickTOKYO, Nov 27 (Reuters) - Oil prices were lower on Friday in quiet trade due to the U.S. Thanksgiving holiday, dropping amid concerns about oversupply and doubts about a vaccine to end the coronavirus pandemic.Bre...
Read more27 Nov 2020 00:01
Britain asks regulator to assess Oxford/AstraZeneca COVID-19 vaccine
LONDON, Nov 27 (Reuters) - Britain on Friday asked its medicine regulator to assess Oxford University and AstraZeneca's COVID-19 vaccine candidate for temporary supply, a step towards beginning a roll-out before the end of the year.AstraZeneca exp...
Read more